Hikma Pharmaceuticals PLC (HIK) Insider Transactions
The most recent insider transactions at Hikma Pharmaceuticals PLC include purchases filed with FCA under MAR Article 19. In September 2026, Susan Ringdal bought 1,684 shares worth £26.9K.
Last updated: 2026-11-20 · Data sourced from MAR Article 19 regulatory disclosures
🔔 Get alerts for Hikma Pharmaceuticals PLC
Be notified when insiders buy or sell Hikma Pharmaceuticals PLC. Free for up to 3 stocks.
Recent Insider Transactions at Hikma Pharmaceuticals PLC
| Date | Insider | Role | Type | Shares | Price | Value | Signals |
|---|---|---|---|---|---|---|---|
| 2026-11-05 | Bassam Kanaan | SELL | 61,941 | £17 | £1.05M | — | |
| 2026-09-21 | Susan Ringdal | BUY | 1,684 | £16 | £26.9K | — | |
| 2026-08-10 | Tobias Hestler | Non-Executive Director | BUY | 7,500 | £16 | £123.6K | — |
| 2026-06-01 | Said Darwazah | CEO | BUY | — | £91.8K | — | — |
| 2026-05-05 | Hussein Arkhagha | BUY | 407 | £14 | £5.7K | — |
Showing last 5 transactions · View all in app →
Live filings with conviction scores, signal badges, and post-trade return tracking.
Insiders Tracked at Hikma Pharmaceuticals PLC
About This Data
InsidersAlpha tracks insider transactions at Hikma Pharmaceuticals PLC filed with FCA under MAR Article 19. Data is sourced directly from official regulatory filings and updated daily. All 6 transactions on record include 5 insider purchases and 1 sale.
The largest single transaction recorded was worth £1.05M by Bassam Kanaan on 2026-11-05.
Frequently Asked Questions
Who are the insiders trading Hikma Pharmaceuticals PLC stock?
Known insiders at Hikma Pharmaceuticals PLC include Bassam Kanaan, Susan Ringdal, Tobias Hestler (Non-Executive Director), Said Darwazah (CEO), Hussein Arkhagha. InsidersAlpha tracks 5 named insiders at Hikma Pharmaceuticals PLC.
When was the last insider buy at Hikma Pharmaceuticals PLC?
The most recent insider purchase at Hikma Pharmaceuticals PLC was by Susan Ringdal on 2026-09-21, buying 1,684 shares at £16 for a total of £26.9K. InsidersAlpha updates daily from official FCA disclosures.
How many insider transactions has Hikma Pharmaceuticals PLC had?
Hikma Pharmaceuticals PLC has had 6 insider transactions tracked on InsidersAlpha, including 5 purchases and 1 sale. The overall buy/sell ratio is 83% buys.
What is the insider buying trend at Hikma Pharmaceuticals PLC?
Over the past 6 months, Hikma Pharmaceuticals PLC insiders have made 3 purchases totaling £150.5K. The insider activity trend is strongly bullish — insiders have made 5 purchases vs 1 sales. Past performance does not guarantee future results — always conduct your own research.